Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Post by foofadoooon Mar 03, 2017 12:21pm
249 Views
Post# 25927531

Our pipeline.....

Our pipeline.....Has just started, the door has been opened we will see steady and progressively better reaction to all news this year. Wait till the Alstrom Syndrome patients side effects (kidney,lung, diabetes etc) start to tickle out. Our year end will reinforce much of this. The FDA will take notice. We also have plasminogen coming on line in mid 2017.....each quarter thereafter should provide improved financial guidance......buy now....if you are unhappy sell. IMHO.....we are sitting on a gold mine!

foof
Bullboard Posts